Benzonatate Capsule
Product Images NDC 67296-1464

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 67296-1464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (4a8b8e96 801e 49de Badb 7be3fbf57baa 01)

FDA Label Image

Container-label-100mg-100 (4a8b8e96 801e 49de Badb 7be3fbf57baa 02)

Container-label-100mg-100 (4a8b8e96 801e 49de Badb 7be3fbf57baa 02)
This is a description of a medication named Benzonatate, available in soft gelatin capsule form. Each capsule contains USP-grade Benzonatate. The dosage and usage instructions must be obtained from the accompanying prescribing information. The medication is manufactured in India by Strides Pharma Science Ltd, but is distributed in the United States by Strides Pharma Inc. Patients should not break, chew, dissolve, cut, or crush the capsules and should swallow them whole. The medication should be protected from light and stored at a temperature between 20° and 25°C (68° to 77°F) with excursions permitted to 15-30°C (59-66°F). The prescription should be dispensed in a tight container. Batch details can be printed on the designated space provided.*
FDA Label Image

Container-label-200mg-100 (4a8b8e96 801e 49de Badb 7be3fbf57baa 03)

FDA Label Image

Container-label-100mg-500s (4a8b8e96 801e 49de Badb 7be3fbf57baa 04)

Container-label-100mg-500s (4a8b8e96 801e 49de Badb 7be3fbf57baa 04)
Each soft gelatin capsule contains 100mg of Benzonatate, USP. It is recommended to swallow the capsules whole and not break, chew, dissolve, cut, or crush them. The capsules should be stored in a tight, child-resistant container at a controlled room temperature between 20 to 25°C with excursions permitted to 15-30°C. Dispensing this drug requires an NDC 64380-712-07 number. This product should be protected from light. It was manufactured by Strides Pharma Science Limited in Bengaluru, India, and distributed by Strides Pharma Inc. in East Brunswick, NJ. The revised date of this information is 7th July 2019.*
FDA Label Image

Container-label-200mg-500s (4a8b8e96 801e 49de Badb 7be3fbf57baa 05)

Container-label-200mg-500s (4a8b8e96 801e 49de Badb 7be3fbf57baa 05)
This text provides dosage and usage information for Benzonatate capsules USP manufactured by Strides Pharma Science Limited. It advises patients to swallow the capsules whole and not break, chew, dissolve, cut or crush them. The capsules should be stored at a temperature between 20 to 25°C and protected from light. The instructions also mention that the capsules should be dispensed in tightly sealed, child-resistant containers. The accompanying prescribing information should be consulted for further details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.